Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study.

Ahmed Abdelhak,Andre Huss,Alexander Stahmann,Makbule Senel,Markus Krumbholz,Markus C Kowarik,Joachim Havla,Tania Kümpfel,Ingo Kleiter, Isabella Wüstinger,Uwe K Zettl,Margit Schwartz,Romy Roesler,Tim Friede,Albert C Ludolph,Ulf Ziemann,Hayrettin Tumani

Contemporary Clinical Trials Communications（2020）

引用 4|浏览55

暂无评分

摘要

This longitudinal multicentre study will reveal to what extent the prediction of disease progression in patients with PMS will be improved by the analysis of serum biomarkers in conjunction with routine clinical data and neuroimaging measures.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要